{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:56:20Z","timestamp":1783428980448,"version":"3.54.6"},"reference-count":62,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA030446"],"award-info":[{"award-number":["DA030446"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA016759"],"award-info":[{"award-number":["DA016759"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA037842"],"award-info":[{"award-number":["DA037842"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Addict"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1111\/ajad.12316","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T21:42:42Z","timestamp":1450734162000},"page":"41-48","source":"Crossref","is-referenced-by-count":21,"title":["Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms"],"prefix":"10.1111","volume":"25","author":[{"given":"Jermaine D.","family":"Jones","sequence":"first","affiliation":[{"name":"Division of Substance Abuse, New York Psychiatric Institute and Department of Psychiatry; College of Physicians and Surgeons of Columbia University; 1051 Riverside Drive, Unit 120 10032 New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel R.","family":"Luba","sequence":"additional","affiliation":[{"name":"Division of Substance Abuse, New York Psychiatric Institute and Department of Psychiatry; College of Physicians and Surgeons of Columbia University; 1051 Riverside Drive, Unit 120 10032 New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Vogelman","sequence":"additional","affiliation":[{"name":"Division of Substance Abuse, New York Psychiatric Institute and Department of Psychiatry; College of Physicians and Surgeons of Columbia University; 1051 Riverside Drive, Unit 120 10032 New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra D.","family":"Comer","sequence":"additional","affiliation":[{"name":"Division of Substance Abuse, New York Psychiatric Institute and Department of Psychiatry; College of Physicians and Surgeons of Columbia University; 1051 Riverside Drive, Unit 120 10032 New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"10.1111\/ajad.12316-BIB0001|ajad12316-cit-0001","unstructured":"2013"},{"key":"10.1111\/ajad.12316-BIB0002|ajad12316-cit-0002","unstructured":"https:\/\/www.unodc.org\/documents\/wdr2014\/World_Drug_Report_2014_web.pdf"},{"key":"10.1111\/ajad.12316-BIB0003|ajad12316-cit-0003","unstructured":""},{"key":"10.1111\/ajad.12316-BIB0004|ajad12316-cit-0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2005.02.005","article-title":"Factors associated with the transition from abuse to dependence among substance abusers: Implications for a measure of addictive liability","volume":"80","author":"Ridenour","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/ajad.12316-BIB0005|ajad12316-cit-0005","volume-title":"Emergency medicine: A comprehensive study guide","author":"Doyon","year":"2004","edition":"6"},{"key":"10.1111\/ajad.12316-BIB0006|ajad12316-cit-0006","volume-title":"Substance abuse: A comprehensive textbook","author":"Jaffe","year":"1997","edition":"3"},{"key":"10.1111\/ajad.12316-BIB0007|ajad12316-cit-0007","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(96)90215-9","article-title":"Are detoxification programmes effective","volume":"347","author":"Mattick","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/ajad.12316-BIB0008|ajad12316-cit-0008","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.psych.53.100901.135142","article-title":"Genetic contributions to addiction","volume":"53","author":"Crabbe","year":"2002","journal-title":"Ann Rev Psychol"},{"key":"10.1111\/ajad.12316-BIB0009|ajad12316-cit-0009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(00)00820-7","article-title":"Pharmacogenomics and addiction to opiates","volume":"410","author":"Lichtermann","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/ajad.12316-BIB0010|ajad12316-cit-0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.0.CO;2-L","article-title":"Genetic influences on DSM-III-R drug abuse and dependence: A study of 3,372 twin pairs","volume":"67","author":"Tsuang","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1111\/ajad.12316-BIB0011|ajad12316-cit-0011","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/10673220127912","article-title":"The harvard twin study of substance abuse: What we have learned","volume":"9","author":"Tsuang","year":"2001","journal-title":"Harv Rev Psychiatry"},{"key":"10.1111\/ajad.12316-BIB0012|ajad12316-cit-0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0893-133X(98)00061-X","article-title":"Molecular genetics of substance abuse vulnerability: A current approach","volume":"20","author":"Uhl","year":"1999","journal-title":"Neuropsychopharmacol"},{"key":"10.1111\/ajad.12316-BIB0013|ajad12316-cit-0013","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1073\/pnas.0600871103","article-title":"Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers","volume":"103","author":"Drakenberg","year":"2006","journal-title":"PNAS"},{"key":"10.1111\/ajad.12316-BIB0014|ajad12316-cit-0014","first-page":"786","article-title":"The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine","volume":"105","author":"Lotsch","year":"2002","journal-title":"Phar Proc Natl Acad Sci USA"},{"key":"10.1111\/ajad.12316-BIB0015|ajad12316-cit-0015","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.0710902105","article-title":"Opioid neuropeptide genotypes in relation to heroin abuse: Dopamine tone contributes to reversed mesolimbic proenkephalin expression","volume":"105","author":"Nikoshkov","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ajad.12316-BIB0016|ajad12316-cit-0016","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.tpj.6500327","article-title":"Clinical response to morphine in cancer patients and genetic variation in candidate genes","volume":"5","author":"Ross","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/ajad.12316-BIB0017|ajad12316-cit-0017","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.biopsych.2006.07.012","article-title":"Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population","volume":"61","author":"Zhang","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1111\/ajad.12316-BIB0018|ajad12316-cit-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.03.003","article-title":"A review of pharmacogenetic studies of drug use disorders","volume":"152","author":"Jones","year":"2015","journal-title":"Drug Alc Depend"},{"key":"10.1111\/ajad.12316-BIB0019|ajad12316-cit-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.fpc.0000182781.87932.0d","article-title":"Pharmacogenetics of opioid receptors and addiction","volume":"16","author":"Mayer","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/ajad.12316-BIB0020|ajad12316-cit-0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.clpt.6100095","article-title":"Pharmacogenetics of opioids","volume":"81","author":"Somogyi","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/ajad.12316-BIB0021|ajad12316-cit-0021","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1111\/ajad.12316-BIB0022|ajad12316-cit-0022","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nature"},{"key":"10.1111\/ajad.12316-BIB0023|ajad12316-cit-0023","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bph.12618","article-title":"The role of \u03b4-opioid receptors in learning and memory underlying the development of addiction","volume":"172","author":"Klenowski","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1111\/ajad.12316-BIB0024|ajad12316-cit-0024","doi-asserted-by":"crossref","first-page":"L50","DOI":"10.1016\/0024-3205(94)00426-S","article-title":"The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine","volume":"56","author":"Kristensen","year":"1995","journal-title":"Life Sci"},{"key":"10.1111\/ajad.12316-BIB0025|ajad12316-cit-0025","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/adb.12169","article-title":"Involvement of \u00b5- and \u03b4-opioid receptor function in the rewarding effect of (\u00b1)-pentazocine","volume":"20","author":"Mori","year":"2014","journal-title":"Addict Biol"},{"key":"10.1111\/ajad.12316-BIB0026|ajad12316-cit-0026","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1098-2396(199911)34:2<83::AID-SYN1>3.0.CO;2-S","article-title":"Opioid peptide receptor studies. 1Buprenorphine is a potent and selective mu\/kappa antagonist in the [35S]-GTP-gamma-S functional binding assay","volume":"34","author":"Romero","year":"1999","journal-title":"Synapse"},{"key":"10.1111\/ajad.12316-BIB0027|ajad12316-cit-0027","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s002130050626","article-title":"Effects of dynorphin A (1-13) on opiate withdrawal in humans","volume":"137","author":"Specker","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1111\/ajad.12316-BIB0028|ajad12316-cit-0028","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/npp.2010.137","article-title":"The therapeutic potential of kappa-opioids for treatment of pain and addiction","volume":"36","author":"Chavkin","year":"2011","journal-title":"Neuropsychopharmacol"},{"key":"10.1111\/ajad.12316-BIB0029|ajad12316-cit-0029","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0165-6147(98)01169-9","article-title":"Mu-Opposing actions of the kappa-opioid receptor","volume":"19","author":"Pan","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/ajad.12316-BIB0030|ajad12316-cit-0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J Neurosci"},{"key":"10.1111\/ajad.12316-BIB0031|ajad12316-cit-0031","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, stress, and depression","volume":"1314","author":"Knoll","year":"2010","journal-title":"Brain Res"},{"key":"10.1111\/ajad.12316-BIB0032|ajad12316-cit-0032","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pharmthera.2013.06.003","article-title":"Delta opioid receptors in brain function and diseases","volume":"140","author":"Chung","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1111\/ajad.12316-BIB0033|ajad12316-cit-0033","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tips.2011.06.008","article-title":"The delta opioid receptor: An evolving target for the treatment of brain disorders","volume":"32","author":"Pradhan","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/ajad.12316-BIB0034|ajad12316-cit-0034","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1476-5381.2012.02075.x","article-title":"Ligand-directed signalling within the opioid receptor family","volume":"167","author":"Pradhan","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1111\/ajad.12316-BIB0035|ajad12316-cit-0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biopsych.2008.09.009","article-title":"Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine","volume":"65","author":"Shippenberg","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1111\/ajad.12316-BIB0036|ajad12316-cit-0036","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1530-0277.2007.00339.x","article-title":"Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: Results from the VA Cooperative Study","volume":"31","author":"Gelernter","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/ajad.12316-BIB0037|ajad12316-cit-0037","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ajmg.b.30510","article-title":"Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction","volume":"144B","author":"Gerra","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1111\/ajad.12316-BIB0038|ajad12316-cit-0038","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","article-title":"Genetic susceptibility to heroin addiction: A candidate gene association study","volume":"7","author":"Levran","year":"2008","journal-title":"Genes Brain Behav"},{"key":"10.1111\/ajad.12316-BIB0039|ajad12316-cit-0039","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/00001756-199707280-00025","article-title":"Association between a delta opioid receptor gene polymorphism and heroin dependence in man","volume":"8","author":"Mayer","year":"1997","journal-title":"Neuroreport"},{"key":"10.1111\/ajad.12316-BIB0040|ajad12316-cit-0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.mp.4002035","article-title":"The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk","volume":"13","author":"Zhang","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1111\/ajad.12316-BIB0041|ajad12316-cit-0041","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1530-0277.2008.00735.x","article-title":"Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers","volume":"32","author":"Arias","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/ajad.12316-BIB0042|ajad12316-cit-0042","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/npp.2013.99","article-title":"An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans","volume":"38","author":"Crist","year":"2013","journal-title":"Neuropsychopharmacol"},{"key":"10.1111\/ajad.12316-BIB0043|ajad12316-cit-0043","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/YPG.0000000000000008","article-title":"The \u03ba-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial","volume":"23","author":"Nielsen","year":"2013","journal-title":"Psychiatr Genet"},{"key":"10.1111\/ajad.12316-BIB0044|ajad12316-cit-0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.03.003","article-title":"A review of pharmacogenetic studies of drug use disorders","volume":"152","author":"Jones","year":"2015","journal-title":"Drug Alc Depend"},{"key":"10.1111\/ajad.12316-BIB0045|ajad12316-cit-0045","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/adb.12163","article-title":"Abuse potential of intranasal buprenorphine versus buprenorphine\/naloxone in buprenorphine-maintained heroin users","volume":"20","author":"Jones","year":"2014","journal-title":"Addict Biol"},{"key":"10.1111\/ajad.12316-BIB0046|ajad12316-cit-0046","volume-title":"Depression: Causes and treatment","author":"Beck","year":"1972"},{"key":"10.1111\/ajad.12316-BIB0047|ajad12316-cit-0047","unstructured":"First MB Spitzer RL Gibbon M 1995"},{"key":"10.1111\/ajad.12316-BIB0048|ajad12316-cit-0048","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"Am J Drug Alc Abuse"},{"key":"10.1111\/ajad.12316-BIB0049|ajad12316-cit-0049","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J Psychoactive Drugs"},{"key":"10.1111\/ajad.12316-BIB0050|ajad12316-cit-0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"10.1111\/ajad.12316-BIB0051|ajad12316-cit-0051","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/hmg\/ddl024","article-title":"Association between two m opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence","volume":"15","author":"Zhang","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1111\/ajad.12316-BIB0052|ajad12316-cit-0052","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050169","article-title":"Endogenous opioid systems and alcohol addiction","volume":"129","author":"Herz","year":"1997","journal-title":"Psychopharmacol"},{"key":"10.1111\/ajad.12316-BIB0053|ajad12316-cit-0053","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/ntr\/ntt046","article-title":"Smoking and opioid detoxification: Behavioral changes and response to treatment","volume":"15","author":"Mannelli","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"10.1111\/ajad.12316-BIB0054|ajad12316-cit-0054","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1213\/ane.0b013e31818c7b99","article-title":"The effects of smoking status on opioid tapering among patients with chronic pain","volume":"108","author":"Hooten","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1111\/ajad.12316-BIB0055|ajad12316-cit-0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2008.06.016","article-title":"Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence","volume":"99","author":"Ziedonis","year":"2009","journal-title":"Drug Alc Depend"},{"key":"10.1111\/ajad.12316-BIB0056|ajad12316-cit-0056","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0376-8716(85)90067-5","article-title":"Buprenorphine","volume":"14","author":"Lewis","year":"1985","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/ajad.12316-BIB0057|ajad12316-cit-0057","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"\u03ba-Opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J Neurosci"},{"key":"10.1111\/ajad.12316-BIB0058|ajad12316-cit-0058","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/JCP.0000000000000082","article-title":"The association of genetic polymorphisms in the \u03ba-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance","volume":"34","author":"Wang","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/ajad.12316-BIB0059|ajad12316-cit-0059","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacol"},{"key":"10.1111\/ajad.12316-BIB0060|ajad12316-cit-0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/ajad.12316-BIB0061|ajad12316-cit-0061","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00005053-198502000-00007","article-title":"Success and failure at outpatient opioid detoxification: Evaluating the process of clonidine- and methadone-assisted withdrawal","volume":"173","author":"Rounsaville","year":"1985","journal-title":"J Nerv Ment Dis"},{"key":"10.1111\/ajad.12316-BIB0062|ajad12316-cit-0062","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1521-0391.2003.tb00654.x","article-title":"Predicting completion of outpatient opioid detoxification with clonidine","volume":"12","author":"Strobbe","year":"2003","journal-title":"Am J Addict"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajad.12316","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajad.12316\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T07:59:41Z","timestamp":1718265581000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajad.12316"}},"subtitle":["Genetic Mediation of Opioid Withdrawal"],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ajad.12316","archive":["Portico"],"relation":{},"ISSN":["1055-0496"],"issn-type":[{"value":"1055-0496","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12,21]]}}}